Drugmakers try to deflect blame | Shawn's story: How his drug benefits help him deal with diabetes | Draft executive order seeks easing of pharma R&D rules
June 23, 2017
FOLLOW PCMA ON TWITTER  Twitter
PCMA SmartBrief
News for the PBM Industry
SIGN UP ⋅   FORWARD ⋅   ARCHIVE
Featured Story
Drugmakers try to deflect blame
As drugmakers push prices higher, some are attacking employers and payers that offer prescription drug coverage, writes John Jones, professor of pharmacy law and ethics. "When it comes to how high drug companies price their products, they want the public to ignore what they spend on marketing and the tax breaks they get for direct-to-consumer advertising," Jones writes.
Orange County Business Journal (Irvine, Calif.)/Opinion (6/19) 
LinkedIn Twitter Facebook Google+ Email
Legislative & Regulatory News
Draft executive order seeks easing of pharma R&D rules
A draft executive order instructs agencies to review policies that could raise the cost of pharmaceutical research and development and to recommend policy changes in fiscal 2019 budget proposals. The draft instructs trade negotiators to seek deals that increase the prices other countries pay for American prescription drugs.
Roll Call (free content) (6/23) 
LinkedIn Twitter Facebook Google+ Email
Drug distributors influence pharmacy prices
Drug distributors AmerisourceBergen, McKesson and Cardinal Health negotiate prices with pharmacies, play a role in setting prices, and issue predictions for drug-price trends.
MarketWatch (6/21) 
LinkedIn Twitter Facebook Google+ Email
Lawmakers ask drugmakers to explain insulin price hikes
Reps. Diana DeGette, D-Colo., and Tom Reed, R-N.Y., sent letters to companies that make insulin and to insurers and pharmacy benefit managers seeking information on price decisions.
The Washington Post (tiered subscription model) (6/22) 
LinkedIn Twitter Facebook Google+ Email
Senate health care bill eliminates mandate, cuts taxes
A Senate health care bill would phase out Medicaid expansion and limit federal funding for the program, eliminate the Affordable Care Act's health insurance mandate, offer lower tax credits than the ACA, repeal some taxes and retroactively reduce capital gains taxes, among other measures.
The Wall Street Journal (tiered subscription model) (6/22) 
LinkedIn Twitter Facebook Google+ Email
  
  
Anyone can hold the helm when the sea is calm.
Publilius Syrus,
writer
LinkedIn Twitter Facebook Google+ Email
  
  
Learn more about PCMA:
Upcoming PCMA Events | PCMA Newsroom
Become a PCMA Affiliate
About PCMA
PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 266 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.

Contact PCMA
Charles Cote
Vice President, Strategic Communications
Sign Up
SmartBrief offers 200+ newsletters
Subscriber Tools:
Contact Us:
Editor  -  Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2017 SmartBrief, Inc.®
Privacy policy |  Legal Information